TTrialPathMatch Me to Trials
← Back to trials
RecruitingPulmonary HypertensionCongestive Heart Failure(CHF)Valve Disease, Heart

Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.

Sponsor: HemoCept Inc.

You may qualify if…

  • Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.
  • Subjects can be any gender but must be age 18 or older.
  • Subject is able and willing to provide informed consent and HIPAA authorization.
  • Subject is able and willing to meet all study requirements.
  • Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible)

You may not qualify if…

  • Subject is pregnant, breastfeeding, or intends to become pregnant during this study.

Where it's recruiting

Colorado

Boulder

Source: ClinicalTrials.gov · NCT07224906 · last updated 2026-04-13

Observational Study of Patients Undergoing Diagnostic Right Heart Cath · TrialPath